BioWorld11 天
KRIYA-497, a one-time muscle-directed AAV1-FGF21 gene therapy for the treatment of MASH
Kriya Therapeutics Inc. and the Universitat Autònoma de Barcelona have published preclinical data for KRIYA-497, a one-time ...